{"SPADE_UN_10342": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 7582301 B1", "Patent Link": "http://www.lens.org/lens/patent/US_7582301_B1", "Patent Type": "Granted Patent", "Publication Date": "2009-9-1", "Family Info": "CA2372338A1,CN1351611A,DE60000665D1,DE60000665T2,DE60000665T3,DE60043021D1,EP1179012A1,EP1179012B1,EP1179012B2,EP1179012B9,EP1264840A1,EP12", "Patent Title": "Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides.", "Abstract": "Peptides exhibiting anti-viral and anti-fusogenic activity are modified to provide greater stability and improved half-life in vivo. The selected peptides include fusion inhibitors DP178 and DP107 and related peptides and analogs thereof. The modified peptides are capable of forming covalent bonds with one or more blood components, preferably a mobile blood component."}], "Sequence Information": {"SPADE ID": "SPADE_UN_10342", "Sequence": "LAVERYLKDQ", "Sequence Length": 10, "Peptide Name": "Sequence 206 from Patent US 7582301", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antiviral"], "Frequent Amino Acids": "LAD", "Absent Amino Acids": "CFGHIMNOPSTUW", "Basic Residues": 2, "Acidic Residues": 2, "Hydrophobic Residues": 5, "Polar Residues": 6, "Positive Residues": 2, "Negative Residues": 2, "Mass": 1234.4, "PI": 6.07, "Net Charge": 0, "Hydrophobicity": -0.66, "Similar Sequences": [{"SPADE_ID": "SPADE_N_04802", "Similarity": 1.0, "Sequence": "TLTVQARQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQLLGI"}, {"SPADE_ID": "SPADE_N_14942", "Similarity": 1.0, "Sequence": "GVLAV"}, {"SPADE_ID": "SPADE_N_14943", "Similarity": 1.0, "Sequence": "GVLAV"}]}}}